Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
60.09
-3.41 (-5.38%)
Jan 29, 2026, 9:50 AM EST - Market open
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $167.38 million as of January 29, 2026. Its market cap has increased by 474.98% in one year.
Market Cap
167.38M
Enterprise Value
157.14M
1-Year Change
474.98%
Ranking
Category
Stock Price
$60.09
Market Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has decreased from $245.32M to $167.38M, a decrease of -31.77%. That is a compound annual growth rate of -4.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 176.90M | 50.69% |
| Dec 31, 2025 | 117.39M | 353.07% |
| Dec 31, 2024 | 25.91M | -15.83% |
| Dec 29, 2023 | 30.78M | -70.81% |
| Dec 30, 2022 | 105.47M | -38.35% |
| Dec 31, 2021 | 171.08M | -24.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kalaris Therapeutics | 174.87M |
| Nkarta | 172.60M |
| Sagimet Biosciences | 169.76M |
| Innate Pharma | 168.84M |
| ProQR Therapeutics | 168.55M |
| Eledon Pharmaceuticals | 166.24M |
| Acumen Pharmaceuticals | 165.97M |
| Protalix BioTherapeutics | 164.46M |